Search clinical trials for: CMD-193

Total 4578 results

Ludwig Institute for Cancer Research
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen

Neoplasms

Australia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating CMD-193 in Advanced Malignant Solid Tumors

Neoplasms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors

Neoplasms

Japan
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393

Type 2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Study to Investigate the PK and Safety of CKD-393

Type II Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

Type II Diabetes Mellitus

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

Type2Diabetes

Korea, Republic of
CASI Pharmaceuticals, Inc.

Active, not recruiting

CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United Kingdom, France
Chong Kun Dang Pharmaceutical

Unknown

Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
University of Maryland, Baltimore

Terminated

Blood Donor CVD 9000

Cholera Vaccination

United States
University of Texas Southwestern Medical Center

Enrolling by invitation

Clinical Outcomes and Radiation Safety After Endovascular Repair of Complex AAAs Using Fenestrated- Branched Devices

Aortic Aneurysm, Abdominal | Thoracic Aneurysm

United States
Hippocration General Hospital
National and Kapodistrian University of Athens; Evangelismos Hospital; Alexandra... and other collaborators

Recruiting

The Role of Sympathetic Tone Regarding the Anatomical and Functional Recovery of the Left Ventricle in TakoTsubo Syndrome (SYMPATAK)

Takotsubo Cardiomyopathy

Greece
Cell Medica Ltd

Terminated

Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (CITADEL)

Lymphoma, Extranodal NK-T-Cell | EBV

Korea, Republic of, United States, France, United Kingdom
Pfizer

Terminated

A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin

Cachexia

United States
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects

Diabetes Mellitus, Type 2

Korea, Republic of
University Hospital Muenster

Not yet recruiting

Semibranch Registry - Retrospective

Aortic Aneurysm | Endovascular Aortic Repair | Stent-Graft Endoleak

Germany
University Hospital Muenster

Recruiting

Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.

Aortic Aneurysm | Endovascular Aortic Repair | Stent-Graft Endoleak

Germany
Samsung Medical Center

Recruiting

Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology (HFrEF-CMD)

Heart Failure | Microvascular Angina | Non-ischemic Cardiomyopathy

Korea, Republic of
Medstar Health Research Institute

Recruiting

Coronary Microvascular Disease (CMD) Registry

Coronary Microvascular Dysfunction

United States
National University of Singapore
KHANA Center for Population Health Research

Recruiting

Community-Based Model for Delivery of Antiretroviral Therapy in Cambodia

HIV Infections | AIDS

Cambodia
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Mexico
Brii Biosciences Limited
TSB Therapeutics (Beijing) CO.LTD

Completed

A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

COVID-19

China
Brii Biosciences Limited
TSB Therapeutics (Beijing) CO.LTD

Completed

A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

COVID-19

China
Brii Biosciences, Inc.

Withdrawn

A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19

COVID-19

China
Second Affiliated Hospital of Soochow University
Shanghai Regenelead Therapies Co., Ltd.

Recruiting

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease

Advanced Parkinson's Disease

China
University of Talca
National Fund for Research and Development in Health, Chile

Not yet recruiting

Collaborative Multidimensional Intervention for Depression in Chile (CMID)

Depression
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)

United States
Hartford Hospital
Yale University

Active, not recruiting

Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task

CBD

United States
M.D. Anderson Cancer Center

Recruiting

Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL

Leukemia | Leukemia, Lymphoblastic

United States
Johns Hopkins University
Cultivate Biologics

Completed

The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A

Cannabis

United States
Five Eleven Pharma, Inc.
Indiana University

Active, not recruiting

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Prostate Cancer | Prostate Cancer Recurrent

United States
Guangdong Provincial Hospital of Traditional Chinese...

Completed

Effect and Safety of TCM-FMD in Phlegm-Dampness Type Overweight/Obesity Patients(EASTAR)

Obesity

China
Amgen

Recruiting

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

MTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid Tumors

Australia, United States
John Sampson

Completed

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer (ERaDICATe)

Glioblastoma

United States
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

Healthy

Korea, Republic of
Novartis Pharmaceuticals

Completed

Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma (COMBI-v)

Melanoma

United States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 (CKD-348)

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

Alopecia

Korea, Republic of
Beckman Coulter, Inc.

Terminated

Clinical Performance Evaluation of DxN CMV Assay

Cytomegalovirus

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

Type 2 Diabetes Mellitus

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A

Alopecia

Korea, Republic of
University of Texas at Austin
Way West Wellness; SunFlora.Inc

Suspended

CBD Oil for Reducing Emotional Impact of COVID-19 (CBDOIL)

Anger | Sleep Disturbance | Anxiety Depression | Substance Abuse | Alcohol Abuse | Stress Reaction

United States
University of Aberdeen

Completed

A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory

Acne Vulgaris

United Kingdom
Chong Kun Dang Pharmaceutical
Seoul National University Bundang Hospital

Completed

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

Healthy

Korea, Republic of
Bo Feng

Completed

Laparoscopic Complete Mesocolic Excision on Colon Cancer (LCME)

Quality of Life | Complications | Pathology | Operation Finding | Neoplasms Recurrence

China
James Weiland

Recruiting

SmartHMD for Improved Mobility

Mobility Limitation | Visual Impairment | Low Vision | Orientation | Navigation, Spatial

United States
Universidad de Granada

Active, not recruiting

Effect of Cannabidiol (CBD) on Vision and Driving

Cannabis Use

Spain
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 (CKD-348)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396

Type2 Diabetes Mellitus

Korea, Republic of

Search clinical trials for: CMD-193

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations